Trending Stock News

Focused Wealth Management Lowered Stake in Target (TGT) by $768,720; Redhill Biopharma LTD (RDHL) Shareholder Bank Hapoalim Bm Has Cut Stake by $396,470 as Stock Price Rose

Focused Wealth Management Inc decreased its stake in Target Corp (TGT) by 97.71% based on its latest 2017Q3 regulatory filing with the SEC. Focused Wealth Management Inc sold 12,812 shares as the company’s stock declined 14.90% while stock markets rallied. The institutional investor held 300 shares of the department and specialty retail stores company at the end of 2017Q3, valued at $18,000, down from 13,112 at the end of the previous reported quarter. Focused Wealth Management Inc who had been investing in Target Corp for a number of months, seems to be less bullish one the $40.99B market cap company. The stock increased 0.51% or $0.38 during the last trading session, reaching $75.41. About 5.48M shares traded. Target Corporation (NYSE:TGT) has declined 16.51% since February 25, 2017 and is downtrending. It has underperformed by 33.21% the S&P500.

Bank Hapoalim Bm decreased its stake in Redhill Biopharma Ltd (RDHL) by 22.57% based on its latest 2017Q3 regulatory filing with the SEC. Bank Hapoalim Bm sold 39,647 shares as the company’s stock rose 0.20% with the market. The institutional investor held 136,012 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.47M, down from 175,659 at the end of the previous reported quarter. Bank Hapoalim Bm who had been investing in Redhill Biopharma Ltd for a number of months, seems to be less bullish one the $129.34 million market cap company. The stock increased 0.80% or $0.05 during the last trading session, reaching $6.28. About 31,843 shares traded. RedHill Biopharma Ltd. (NASDAQ:RDHL) has declined 9.09% since February 25, 2017 and is downtrending. It has underperformed by 25.79% the S&P500.

Focused Wealth Management Inc, which manages about $364.20 million and $299.86M US Long portfolio, upped its stake in Vanguard Whitehall Fds Inc (VYM) by 106,274 shares to 406,789 shares, valued at $32.98M in 2017Q3, according to the filing. It also increased its holding in Vanguard Index Fds (VTV) by 5,523 shares in the quarter, for a total of 31,945 shares, and has risen its stake in Vanguard World Fds (VHT).

Analysts await Target Corporation (NYSE:TGT) to report earnings on March, 6 before the open. They expect $1.39 EPS, down 4.14% or $0.06 from last year’s $1.45 per share. TGT’s profit will be $755.57 million for 13.56 P/E if the $1.39 EPS becomes a reality. After $0.91 actual EPS reported by Target Corporation for the previous quarter, Wall Street now forecasts 52.75% EPS growth.

Among 28 analysts covering Target Corporation (NYSE:TGT), 9 have Buy rating, 3 Sell and 16 Hold. Therefore 32% are positive. Target Corporation had 84 analyst reports since July 21, 2015 according to SRatingsIntel. Jefferies maintained it with “Hold” rating and $5900 target in Tuesday, July 25 report. As per Thursday, August 31, the company rating was maintained by Jefferies. The company was maintained on Monday, October 2 by Robert W. Baird. BMO Capital Markets maintained Target Corporation (NYSE:TGT) rating on Thursday, July 13. BMO Capital Markets has “Hold” rating and $6200 target. The company was maintained on Thursday, February 4 by Piper Jaffray. Wolfe Research downgraded the shares of TGT in report on Wednesday, March 1 to “Underperform” rating. The firm earned “Neutral” rating on Wednesday, June 21 by Citigroup. The firm has “Neutral” rating given on Friday, February 10 by Susquehanna. Stifel Nicolaus maintained the shares of TGT in report on Thursday, November 16 with “Hold” rating. The firm has “Buy” rating by Vetr given on Tuesday, August 25.

Among 8 analysts covering RedHill Biopharma (NASDAQ:RDHL), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. RedHill Biopharma had 14 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of RedHill Biopharma Ltd. (NASDAQ:RDHL) earned “Buy” rating by H.C. Wainwright on Thursday, June 15. The stock of RedHill Biopharma Ltd. (NASDAQ:RDHL) has “Buy” rating given on Wednesday, July 29 by TH Capital. The rating was initiated by Northland Capital on Tuesday, September 29 with “Buy”. The rating was maintained by FBR Capital with “Outperform” on Friday, February 24. The firm has “Sell” rating by Zacks given on Saturday, August 22. The rating was maintained by Roth Capital with “Buy” on Monday, July 31. The stock of RedHill Biopharma Ltd. (NASDAQ:RDHL) has “Buy” rating given on Tuesday, November 14 by Roth Capital. The stock of RedHill Biopharma Ltd. (NASDAQ:RDHL) has “Buy” rating given on Thursday, June 15 by FBR Capital. The stock of RedHill Biopharma Ltd. (NASDAQ:RDHL) earned “Buy” rating by Nomura on Tuesday, September 29. The rating was downgraded by TheStreet to “Hold” on Tuesday, August 25.

Leave a Reply

Your email address will not be published. Required fields are marked *